175 related articles for article (PubMed ID: 34727578)
21. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
[TBL] [Abstract][Full Text] [Related]
22. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
[TBL] [Abstract][Full Text] [Related]
23. IgM Antibody Repertoire Fingerprints in Mice Are Personalized but Robust to Viral Infection Status.
Yermanos A; Kräutler NJ; Pedrioli A; Menzel U; Greiff V; Stadler T; Oxenius A; Reddy ST
Front Cell Infect Microbiol; 2020; 10():254. PubMed ID: 32547966
[TBL] [Abstract][Full Text] [Related]
24. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
[TBL] [Abstract][Full Text] [Related]
25. An MHC class Ib-restricted CD8+ T cell response to lymphocytic choriomeningitis virus.
Chen L; Jay DC; Fairbanks JD; He X; Jensen PE
J Immunol; 2011 Dec; 187(12):6463-72. PubMed ID: 22084437
[TBL] [Abstract][Full Text] [Related]
26. Public, private and non-specific antibodies induced by non-cytopathic viral infections.
Recher M; Hunziker L; Ciurea A; Harris N; Lang KS
Curr Opin Microbiol; 2004 Aug; 7(4):426-33. PubMed ID: 15358263
[TBL] [Abstract][Full Text] [Related]
27. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
28. Interrogating Adaptive Immunity Using LCMV.
Dangi T; Chung YR; Palacio N; Penaloza-MacMaster P
Curr Protoc Immunol; 2020 Sep; 130(1):e99. PubMed ID: 32940427
[TBL] [Abstract][Full Text] [Related]
29. Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.
Thomsen AR; Volkert M; Marker O
Immunology; 1985 Jun; 55(2):213-23. PubMed ID: 4007926
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
31. Antiviral antibody-producing cells in parenchymatous organs during persistent virus infection.
Moskophidis D; Löhler J; Lehmann-Grube F
J Exp Med; 1987 Mar; 165(3):705-19. PubMed ID: 3546579
[TBL] [Abstract][Full Text] [Related]
32. Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains.
Ahmed R; Byrne JA; Oldstone MB
J Virol; 1984 Jul; 51(1):34-41. PubMed ID: 6610062
[TBL] [Abstract][Full Text] [Related]
33. Long-term antibody production is sustained by antibody-secreting cells in the bone marrow following acute viral infection.
Slifka MK; Ahmed R
Ann N Y Acad Sci; 1996 Oct; 797():166-76. PubMed ID: 8993360
[TBL] [Abstract][Full Text] [Related]
34. IRF9 Prevents CD8
Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
[TBL] [Abstract][Full Text] [Related]
35. The analysis of clonal expansions in normal and autoimmune B cell repertoires.
Hershberg U; Luning Prak ET
Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1676):. PubMed ID: 26194753
[TBL] [Abstract][Full Text] [Related]
36. Role of viral strains and host genes in determining levels of immune complexes in a model system: implications for HIV infection.
Tishon A; Salmi A; Ahmed R; Oldstone MB
AIDS Res Hum Retroviruses; 1991 Dec; 7(12):963-9. PubMed ID: 1812945
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
Senn BM; López-Macías C; Kalinke U; Lamarre A; Isibasi A; Zinkernagel RM; Hengartner H
Eur J Immunol; 2003 Apr; 33(4):950-61. PubMed ID: 12672061
[TBL] [Abstract][Full Text] [Related]
38. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
[TBL] [Abstract][Full Text] [Related]
39. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
Matloubian M; Concepcion RJ; Ahmed R
J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.
Lee J; Hashimoto M; Im SJ; Araki K; Jin HT; Davis CW; Konieczny BT; Spies GA; McElrath MJ; Ahmed R
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]